Persistent systemic inflammation, a typical feature of inflammatory rheumatic diseases, is
associated with a high cardiovascular risk and predisposes to metabolic disorders and …

Efforts to develop a consensus definition are ongoing and will greatly facilitate the
development and testing of novel interventions for sarcopenia. Although pharmaceutical …

Sarcopenia a recognised geriatric syndrome. This study aims to evaluate the prevalence of
possible sarcopenia, sarcopenia and severe sarcopenia among older Chinese adults and to …

Rheumatoid arthritis (RA) has long been associated with increased cardiovascular risk, but
despite substantial improvements in disease management, mortality remains high …

Sarcopenia refers to a decrease in skeletal muscle mass and function. Because sarcopenia
affects mortality, and causes significant disability, the clinical importance of sarcopenia is …

The prevalence of sarcopenia in rheumatic diseases has been evaluated in single diseases
using various diagnostic approaches, generating conflicting data on the pathogenetic …

Frailty is a new concept in rheumatology that can help identify people more likely to have
less favorable outcomes. Sarcopenia and inflammaging can be regarded as the biological …

Results It was found that skeletal muscle index (SMI) was lower in patients with RA
(5.83±0.807) than in controls (7.30±1.640). Sarcopenia (in females with an SMI of≤ 5.75 …

Objective To quantify muscle outcomes, independent of fat mass, in rheumatoid arthritis (RA)
patients compared to healthy controls. Methods Quantitative computed tomography scans …

The increased risk of cardiovascular disease (CVD) in rheumatoid arthritis (RA) has been
recognized for many years. However, although the characteristics of CVD and its burden …